[go: up one dir, main page]

DE60203599D1 - Methode zur Inaktivierung von TSE - Google Patents

Methode zur Inaktivierung von TSE

Info

Publication number
DE60203599D1
DE60203599D1 DE60203599T DE60203599T DE60203599D1 DE 60203599 D1 DE60203599 D1 DE 60203599D1 DE 60203599 T DE60203599 T DE 60203599T DE 60203599 T DE60203599 T DE 60203599T DE 60203599 D1 DE60203599 D1 DE 60203599D1
Authority
DE
Germany
Prior art keywords
tse
inactivating
inactivating tse
infected
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE60203599T
Other languages
English (en)
Other versions
DE60203599T2 (de
Inventor
Neil D H Raven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Public Health England
Original Assignee
Health Protection Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26245535&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60203599(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0100420A external-priority patent/GB0100420D0/en
Priority claimed from GB0104696A external-priority patent/GB0104696D0/en
Application filed by Health Protection Agency filed Critical Health Protection Agency
Publication of DE60203599D1 publication Critical patent/DE60203599D1/de
Application granted granted Critical
Publication of DE60203599T2 publication Critical patent/DE60203599T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/22—Phase substances, e.g. smokes, aerosols or sprayed or atomised substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/02—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air by heating or combustion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2872—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against prion molecules, e.g. CD230
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38618—Protease or amylase in liquid compositions only
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Enzymes And Modification Thereof (AREA)
DE60203599T 2001-01-08 2002-01-08 Methode zur Inaktivierung von TSE Revoked DE60203599T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0100420A GB0100420D0 (en) 2001-01-08 2001-01-08 Degradation of TSE and similar agents
GB0100420 2001-01-08
GB0104696 2001-02-26
GB0104696A GB0104696D0 (en) 2001-02-26 2001-02-26 Degradation of tse and similar agents
PCT/GB2002/000052 WO2002053723A2 (en) 2001-01-08 2002-01-08 Degradation and detection of tse infectivity

Publications (2)

Publication Number Publication Date
DE60203599D1 true DE60203599D1 (de) 2005-05-12
DE60203599T2 DE60203599T2 (de) 2006-01-19

Family

ID=26245535

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60203599T Revoked DE60203599T2 (de) 2001-01-08 2002-01-08 Methode zur Inaktivierung von TSE

Country Status (10)

Country Link
EP (2) EP1360282B1 (de)
JP (2) JP4427252B2 (de)
AT (1) ATE292679T1 (de)
AU (1) AU2002219336C1 (de)
CA (1) CA2434129A1 (de)
DE (1) DE60203599T2 (de)
ES (1) ES2237675T3 (de)
HK (1) HK1057062A1 (de)
PT (1) PT1360282E (de)
WO (1) WO2002053723A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7303907B2 (en) 2001-01-08 2007-12-04 Health Protection Agency Degradation and detection of TSE infectivity
AUPR293801A0 (en) 2001-02-07 2001-03-01 Novapharm Research (Australia) Pty Ltd Prion disinfection
US7691639B2 (en) 2001-05-31 2010-04-06 Adlyfe, Inc. Misfolded protein sensor method
DE10203225A1 (de) 2002-01-28 2003-07-31 Weigert Chem Fab Reinigung chirurgischer Instrumente
NZ539645A (en) 2002-10-24 2009-04-30 Meiji Seika Kaisha Low cost enzyme that exhibits high activity in digesting a protein highly resistant to denaturation and degradation (particularly a pathogenic prion protein) in comparison with known proteases
EP1575623A1 (de) * 2002-11-01 2005-09-21 Medical Research Council Priondekontamination
GB2394663B (en) * 2002-11-01 2006-07-12 Medical Res Council Prion decontamination
GB0406427D0 (en) 2004-03-22 2004-04-21 Health Prot Agency Biological indicator
CN101156068B (zh) 2005-02-15 2015-03-18 阿德利夫股份有限公司 检测错折叠蛋白和朊病毒的方法
EP2089065B1 (de) 2006-10-27 2015-01-21 E.I. Du Pont De Nemours And Company Verfahren zur prionendekontaminierung
US7922970B2 (en) * 2007-04-03 2011-04-12 Kimberly-Clark Worldwide, Inc. Use of sonication to eliminate prions
US8293174B2 (en) 2007-10-17 2012-10-23 American Sterilizer Company Prion deactivating composition and methods of using same
WO2010021375A1 (ja) * 2008-08-22 2010-02-25 国立大学法人大阪大学 プロテアーゼの製造方法、並びにプロテアーゼ溶液およびプロテアーゼのプロ体溶液
US20120107321A1 (en) * 2009-03-02 2012-05-03 The University Of British Columbia Antibodies And Epitopes Specific To Misfolded Prion Protein
SI2311323T1 (sl) * 2009-10-19 2013-06-28 Univerza V Ljubljani Metode za degradacijo proteinskih depozitov in prionov
US10246731B2 (en) 2016-03-29 2019-04-02 Oneighty°C Technologies Corporation Method for rapidly determining effective sterilization , deimmunization, and/or disinfection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3042860A1 (de) * 1980-11-13 1982-06-09 Heyl & Co Chemisch-Pharmazeutische Fabrik, 1000 Berlin Kollagenpraeparate, verfahren zu ihrer herstellung und ihre verwendung in der human- und veterinaermedizin
US4614549A (en) * 1983-10-24 1986-09-30 Bausch & Lomb Incorporated Method for enzymatic cleaning and disinfecting contact lenses
US5223166A (en) * 1986-11-17 1993-06-29 Henkel Kommanditgesellschaft Auf Aktien Preparations and processes for cleaning and disinfecting endoscopes
DE3816734A1 (de) * 1988-05-17 1989-11-30 Henkel Kgaa Verfahren zur reinigung und desinfektion von hitze- und korrosionsempfindlichen medizinischen geraeten, insbesondere von endoskopen und mittel zur durchfuehrung des verfahrens
DE59507049D1 (de) * 1995-03-01 1999-11-18 Weigert Chem Fab Reinigungsmittel für chirurgische Instrumente
WO1997028192A1 (en) * 1996-01-29 1997-08-07 Charles Doillon Prion-free collagen and collagen-derived products and implants for multiple biomedical applications; methods of making thereof
DE19730132C2 (de) * 1997-07-14 2000-01-20 Fraunhofer Ges Forschung Verfahren zum Nachweis von Prionen sowie eine Vorrichtung hierzu
US20020192731A1 (en) * 2001-04-12 2002-12-19 H. Shih Jason C. Method and composition for sterilizing surgical instruments
EP1251138B1 (de) * 2001-04-19 2006-07-26 Hermann Dr. Schätzl Prion Proteindimere für Impfungen

Also Published As

Publication number Publication date
HK1057062A1 (en) 2004-03-12
WO2002053723A3 (en) 2002-12-12
WO2002053723A2 (en) 2002-07-11
EP1577382A3 (de) 2006-08-30
ES2237675T3 (es) 2005-08-01
ATE292679T1 (de) 2005-04-15
AU2002219336C1 (en) 2008-08-14
CA2434129A1 (en) 2002-07-11
EP1577382A2 (de) 2005-09-21
JP2008174568A (ja) 2008-07-31
PT1360282E (pt) 2005-06-30
JP4427587B2 (ja) 2010-03-10
EP1360282B1 (de) 2005-04-06
JP4427252B2 (ja) 2010-03-03
EP1360282A2 (de) 2003-11-12
JP2004516845A (ja) 2004-06-10
AU2002219336B2 (en) 2005-04-14
DE60203599T2 (de) 2006-01-19
WO2002053723B1 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
DE60203599D1 (de) Methode zur Inaktivierung von TSE
ATE509120T1 (de) Fusionsproteine zur detektion von analyten
ATE385259T1 (de) Verfahren zum nachweis von influenza a/b-viren in speichel
ATE466659T1 (de) Probenahmesystem mit phosphataseinhibitor
ATE412774T1 (de) Parallele genotypisierung mehrerer patientenproben
HK1118044A1 (en) Dimeric iap inhibitors iap
DE60300339D1 (de) Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
ATE525649T1 (de) Nachweis von proteinen mit veränderter konformation
ATE432358T1 (de) Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren
CY1111371T1 (el) Αντισωματα bag3 για χρηση σε ερευνα, διαγνωση και θεραπεια ασθενειων που σχετιζονται με κυτταρικο θανατο
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
DE602006015330D1 (de) Nachweis und messung einer blutzuführungsaktivität
ATE487142T1 (de) Proteinnachweisreagentien und -verfahren mit farbstoffen und dextrinen
BR0314155A (pt) Métodos para diagnosticar câncer cervical
GB0805608D0 (en) Detection method
NO20006109D0 (no) Analytisk metode som beskytter multippel virusmerking
DE602006015702D1 (de) Unterscheidung zwischen baktiereller meningitis und viraler meningitis
ATE493432T1 (de) Gewinnung von hitzeschockproteinen
ATE545460T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
DE50101520D1 (de) Kompetitives assay-verfahren
BR0213997A (pt) Métodos de detecção e identificação de bactérias entéricas
DE602005006633D1 (de) Reagenziensatz zum Nachweis von Lupus-Antikoagulant.
ATE555385T1 (de) N1,n12-diacetylspermin als tumormarker
ATE421686T1 (de) Multiküvettenrotor
ATE354681T1 (de) Nachweis des virus der viralen rinderdiarrhoe in gewebsproben

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation